Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Finalist of EIT Health Wild Card Programme 2023

Events, News

Gate2Brain has proudly earned a spot as a finalist in the esteemed 2023 EIT Health Wild Card Programme, alongside six other promising startups!

The two-month Wild Card program, in which Gate2Brain has actively engaged, encourages participants to think outside the box and challenge conventional thinking. With the guidance and support of experts and investors, teams have the opportunity to take on the challenge and bring innovative products and services to the healthcare industry.

We are thrilled to announce our participation in the EIT Health “Wild Card” project finale, where startups from across Europe will present their innovative solutions in the paediatric domain. This finale will take place during  PediatricInnovation Day organised by i4KIDS I i4KIDS-EUROPE that aims to integrate the European paediatric sector and help develop innovative solutions to enhance children’s healthcare.

This event, scheduled for 27th October, 2023, will be hosted by the K.I.D.S. Foundation in Warsaw, Poland. As part of their exciting program (you can view the full program by following the link below), our CEO, Meritxell Teixido, will deliver a compelling 6-minute pitch alongside fellow selected startups.

Programme

When imagination meets healing!

October 19, 2023/by noticias
Tags: EIT Health, i4kids, Pediatric Innovation Day, wild card
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/10/WILD-CARD-2.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-10-19 07:56:252024-02-20 05:45:27Finalist of EIT Health Wild Card Programme 2023
You might also like
Gate2Brain at the i4KIDS I i4KIDS-EUROPE Pediatric Innovation Training Capsules
Pediatric Innovation Dayi4kidsPediatric Innovation Day
Gate2Brain honored with an award as part of the EIT Health “Wild Card” program
📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
G2B at Pediatric Diffuse Midline Glioma International Meeting33rd Barcelona Investment Healthcare Forum
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}